Instrument Inactif

Communiqués Salix Pharmaceuticals, Ltd.

Actions

US7954351067

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Salix Pharmaceuticals : Confirms Receipt of an Unsolicited Proposal from Endo International plc	11/03/15	BU
Salix Pharmaceuticals : Reports 4Q2014 and FY2014 Results	02/03/15	BU
Salix Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	27/02/15	PR
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2019	25/02/15	BU
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due 2015	25/02/15	BU
Salix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Salix Pharmaceuticals Ltd.	24/02/15	PR
Salix Pharmaceuticals : Announces 4Q and FY2014 Financial Results Conference Call and Webcast	16/02/15	BU
Salix Pharmaceuticals : Announces the Promotion of William P. Forbes, PharmD to President, Medical, R&D and Chief Development Officer	02/02/15	BU
Salix Pharmaceuticals : Federman & Sherwood : Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws	30/01/15	BU
Salix Pharmaceuticals : Provides Update on Audit Committee Review	28/01/15	BU
Salix Pharmaceuticals : The Shuman Law Firm : Investigates Salix Pharmaceuticals Ltd.	10/01/15	BU
Salix Pharmaceuticals : Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals	05/01/15	BU
Salix Pharmaceuticals : INVESTOR ALERT: Investors of Salix Pharmaceuticals, Ltd. with Losses of $100,000 or More Are Encouraged to Contact Law Offices of Howard G. Smith	02/01/15	BU
Salix Pharmaceuticals : Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP	17/12/14	BU
Salix Pharmaceuticals : Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for IBS-D Approval Timeline, and Provides Preliminary Guidance for 2015 and 2016	16/12/14	BU
Salix Pharmaceuticals : Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action Litigation - SLXP	11/12/14	BU
Salix Pharmaceuticals : Announces Plan to Augment Board of Directors	24/11/14	BU
Salix Pharmaceuticals : INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO	08/11/14	BU
Salix Pharmaceuticals : Harwood Feffer LLP : Announces Investigation of Salix Pharmaceuticals Ltd.	08/11/14	PR
Salix Pharmaceuticals : Federman & Sherwood : Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws	07/11/14	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Salix Pharmaceuticals, Ltd.

Actions

US7954351067

Communiqués

Filtres